AMARIN CORP PLC\UK Total Contract Liability
AMARIN CORP PLC\UK (AMRN) had Total Contract Liability of $0 as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-03-02
- 2025-12-31: Contract with Customer, Liability $0.00.
- 2025-09-30: Contract with Customer, Liability $0.00.
- 2025-06-30: Contract with Customer, Liability $0.00.
- 2025-03-31: Contract with Customer, Liability $0.00.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-02 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-02 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-07-30 | |
| 2024-03-31 | $4.45M 10-Q · filed 2025-05-07 | |
| 2023-12-31 | $4.85M 10-K · filed 2026-03-02 | |
| 2023-09-30 | $4.97M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $5.36M 10-Q · filed 2024-07-31 | |
| 2023-03-31 | $14.90M 10-Q · filed 2024-05-01 | |
| 2022-12-31 | $15.35M 10-K · filed 2025-03-12 | |
| 2022-09-30 | $15.70M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $16.01M 10-Q · filed 2023-08-02 | |
| 2022-03-31 | $16.34M 10-Q · filed 2023-05-03 | |
| 2021-12-31 | $16.71M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $17.13M 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $17.97M 10-Q · filed 2022-08-03 | $17.47M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $17.97M 10-Q · filed 2022-05-04 | |
| 2020-12-31 | $18.63M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $18.91M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $20.21M 10-Q · filed 2021-08-05 | $20.21M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $21.81M 10-Q · filed 2021-04-29 | |
| 2019-12-31 | $20.85M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $19.58M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $19.74M 10-Q · filed 2020-08-04 | |
| 2019-03-31 | $20.16M 10-Q · filed 2020-04-30 | |
| 2018-12-31 | $20.71M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $20.96M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $18.81M 10-Q · filed 2019-07-31 | |
| 2017-12-31 | $19.05M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |